Cytotoxic markers associate with protection against malaria in human volunteers immunized with Plasmodium falciparum sporozoites. - Wikidata - wikimedia - TriplyDB

Cytotoxic markers associate with protection against malaria in human volunteers immunized with Plasmodium falciparum sporozoites.

Cytotoxic markers associate with protection against malaria in human volunteers immunized with Plasmodium falciparum sporozoites.

http://www.wikidata.org/entity/Q34399831

about

CD4 T-cell subsets in malaria: TH1/TH2 revisited Protective immunity to liver-stage malaria Malaria vaccine clinical trials: what's on the horizon The March Toward Malaria Vaccines Sporozoite immunization of human volunteers under mefloquine prophylaxis is safe, immunogenic and protective: a double-blind randomized controlled clinical trial New gorilla adenovirus vaccine vectors induce potent immune responses and protection in a mouse malaria model.Expansion of IgG+ B-cells during mitogen stimulation for memory B-cell ELISpot analysis is influenced by size and composition of the B-cell pool.Memory B-cell and antibody responses induced by Plasmodium falciparum sporozoite immunization.The case for a rational genome-based vaccine against malaria.Blood-stage immunity to Plasmodium chabaudi malaria following chemoprophylaxis and sporozoite immunization Studying the effect of chloroquine on sporozoite-induced protection and immune responses in Plasmodium berghei malaria Impact of malaria preexposure on antiparasite cellular and humoral immune responses after controlled human malaria infection.Heterologous Protection against Malaria after Immunization with Plasmodium falciparum Sporozoites.Mechanisms of stage-transcending protection following immunization of mice with late liver stage-arresting genetically attenuated malaria parasites.Breadth of humoral response and antigenic targets of sporozoite-inhibitory antibodies associated with sterile protection induced by controlled human malaria infection Vaccination Produces CD4 T Cells with a Novel CD154-CD40-Dependent Cytolytic Mechanism Reduced Plasmodium Parasite Burden Associates with CD38+ CD4+ T Cells Displaying Cytolytic Potential and Impaired IFN-γ Production Macrophage Colony Stimulating Factor Derived from CD4+ T Cells Contributes to Control of a Blood-Borne Infection Safety, Immunogenicity, and Protective Efficacy of Intradermal Immunization with Aseptic, Purified, Cryopreserved Plasmodium falciparum Sporozoites in Volunteers Under Chloroquine Prophylaxis: A Randomized Controlled Trial.Effective Antimalarial Chemoprevention in Childhood Enhances the Quality of CD4+ T Cells and Limits Their Production of Immunoregulatory Interleukin 10.Diagnosis and treatment based on quantitative PCR after controlled human malaria infection.Transcriptomic evidence for modulation of host inflammatory responses during febrile Plasmodium falciparum malaria.Measurement of the T Cell Response to Preerythrocytic Vaccination in Mice.Live attenuated pre-erythrocytic malaria vaccines.The march toward malaria vaccines.High pathogen burden in childhood promotes the development of unconventional innate-like CD8+ T cells.Infectivity of Plasmodium falciparum sporozoites determines emerging parasitemia in infected volunteers.An expanding toolkit for preclinical pre-erythrocytic malaria vaccine development: bridging traditional mouse malaria models and human trials.Development of whole sporozoite malaria vaccines.Cross-stage immunity for malaria vaccine development.Vaccines to Accelerate Malaria Elimination and Eventual Eradication.Modest heterologous protection after Plasmodium falciparum sporozoite immunization: a double-blind randomized controlled clinical trial.Protective immunity differs between routes of administration of attenuated malaria parasites independent of parasite liver load.Adjuvanting a viral vectored vaccine against pre-erythrocytic malaria.Ex vivo lymphocyte phenotyping during Plasmodium falciparum sporozoite immunization in humans.The role of toll-like receptor 4 in tumor microenvironment.Controlled Human Malaria Infection: Applications, Advances and Challenges.Changes in total and differential leukocyte counts during the clinically silent liver phase in a controlled human malaria infection in malaria-naïve Dutch volunteers.Humoral protection against mosquito bite-transmitted Plasmodium falciparum infection in humanized mice.Differential expression pattern of co-inhibitory molecules on CD4+ T cells in uncomplicated versus complicated malaria.

P2860

Q26849470-E5EE5E3B-C653-4825-963F-347B17F176AA Q28068626-C10275AD-4BAA-48BC-85CA-AB61A8644589 Q28083110-D08AA253-A94C-4E2B-8C47-E3D126AC21BC Q28084325-4E2ACCE4-BE1C-4E31-B1A6-88BAED86B299 Q28544964-1F706AA4-54C1-45EE-A5A7-D6168BE036A7 Q33868760-F7F11E2B-1B95-4080-9171-FC4CAF05BDF6 Q33933486-629CA2C7-3CF2-4A15-AAFF-2288432D7EB9 Q34563555-A7E3F08D-AF9D-4618-8191-A64E0794FBA9 Q34999392-8BACA23C-12B9-4D88-9556-3709179C2DD9 Q35211003-0A8B4E2F-4F93-4D50-B744-12F690F15A3C Q35314263-D24A8A47-57BE-43BE-9943-5CCFD4A5A5EC Q35439859-00773DC5-F092-48E3-83D0-E3E618211C11 Q35560599-F74EA2AB-83B1-4905-870B-1EF87BF77529 Q35606514-D83E8924-74C6-4BB2-AFB6-D4AC0D269F98 Q36004060-39189340-B465-484F-8F33-F62FC1C0A285 Q36075279-8F157BA3-6E36-46E1-AE29-ACB3FFEE1D53 Q36143186-2A73E6AE-E020-4EDD-ACFD-17A4F55985DE Q36214299-5360251E-1BA6-4E0A-8101-4AF1AF858874 Q36644534-B2E638E2-2D2E-49BA-ADA4-B26E9F86B71C Q37033079-01D8608D-5514-4B3B-A23A-6222002F4D63 Q37154138-CE79C7C7-E77E-4CA7-A8EA-53E07FD6842C Q37163165-5D8AE9CF-47C1-46CE-94A4-900DB67B9B96 Q37385314-36C9154E-4ECC-4B5B-AD65-E1284C68B989 Q38284696-0F224451-1C4B-4524-A2A0-2D21B2A83F5C Q38577638-1DA66400-A563-4A7B-B3D9-F05F64835AA9 Q38645940-ABD9DD6F-C59B-48CE-A3E6-73E7D0C5B6F6 Q38714971-B7F22B1D-E473-4BE9-BB3A-1B8659B6B03C Q38794455-3F85EB19-0998-4187-83B1-7652880D45AF Q38872073-D7864AE1-DEA9-4E16-BB95-F27D2FD75759 Q38953222-38F3CEDF-420E-464C-959B-DD42170A5F26 Q39296506-EA1A7661-DDEC-43AD-ADAC-A632188F4FAB Q40042826-0E0B09E5-E6F6-44D1-98CE-7538EA1FCEC2 Q40067174-10BCACDC-C73D-45C9-B916-9313E98ED03D Q40094062-B13E25BE-51C9-4D81-BAE4-60B55AA4C1D4 Q41003777-A5FA4DD7-B2E9-473F-92F4-F7A69C1A9C13 Q42371680-F18C26EA-B1B1-4824-ABFC-D8ABFDDBE517 Q44168331-86A50144-34C7-4248-8355-E35E1144461F Q44169768-21FAE3C6-9E5F-4690-99A0-2A1EDB21CDA9 Q47099112-A2254D37-D004-4D3F-96B1-24DF47454320 Q52647950-002D2A10-0E7E-469A-83C2-FD4D9688175A

P2860

Cytotoxic markers associate with protection against malaria in human volunteers immunized with Plasmodium falciparum sporozoites.

http://www.wikidata.org/entity/Q34399831

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Cytotoxic markers associate wi ...... modium falciparum sporozoites.

@ast

Cytotoxic markers associate wi ...... modium falciparum sporozoites.

@en

Cytotoxic markers associate wi ...... modium falciparum sporozoites.

@nl

type

label

Cytotoxic markers associate wi ...... modium falciparum sporozoites.

@ast

Cytotoxic markers associate wi ...... modium falciparum sporozoites.

@en

Cytotoxic markers associate wi ...... modium falciparum sporozoites.

@nl

prefLabel

Cytotoxic markers associate wi ...... modium falciparum sporozoites.

@ast

Cytotoxic markers associate wi ...... modium falciparum sporozoites.

@en

Cytotoxic markers associate wi ...... modium falciparum sporozoites.

@nl

P1433

Q34399831-07C813F7-6172-4433-8E8A-1C084E5104CD

P1476

Q34399831-02AB28E9-B2D1-42D4-9B29-85C4AE640D73

P2093

Q34399831-18666B86-8AEA-46C9-8ABF-1E8A51F3871E

Q34399831-24B51F48-FD62-48F4-8731-5A47F9A57079

Q34399831-B21EBF4C-05ED-46ED-BF22-39FAD99F5157

Q34399831-BE824033-BC49-4C94-9379-6AD3D25B068A

Q34399831-D4794A0A-2B7D-487D-8BE8-413D22DF9FBD

P2860

Q34399831-01569384-0EB7-402D-AB7E-39E8B858F75A

Q34399831-01DC3CF5-1104-4BBE-8D1B-D9D669E78753

Q34399831-0BEB831C-4914-46E0-9B88-C40981AF2EB5

Q34399831-0E8CC38A-CE67-4EB2-894B-374BFFA4D99C

Q34399831-0F452AB5-F189-47F4-82DE-982779E484A2

Q34399831-10F768D2-BD58-4F9B-8C4A-8ACAC3411A62

Q34399831-1122690B-5AFA-45D5-A540-E50D6F8BE0ED

Q34399831-127F88AB-608C-4EE6-AED4-6CB60AE8B71E

Q34399831-164D9DEA-1D53-4E97-9D1D-649018850D61

Q34399831-222DA536-1DB1-4293-BBB9-DCB218D02382

P304

Q34399831-74FE71CF-DD15-4184-8FB1-EB6B3AE22B2D

P31

Q34399831-D7E09324-3259-4AB1-B293-2B0CA9E18073

P356

Q34399831-F646FC4A-DE32-4A49-BB4A-786E06025DEF

P407

Q34399831-4076EE96-CF97-4B48-8F74-70792C1A0281

P433

Q34399831-069FE9C8-AD75-45A8-A4E6-1621DACE6591

P478

Q34399831-A203FC31-1F9C-46E8-A86D-04F08AC2BA47

P50

Q34399831-442659C8-038B-459D-9A36-A1FFA0A0A358

Q34399831-90FE8E0D-94BE-49AB-9EF2-B66C318D37D7

Q34399831-94425A2F-CF1F-48D5-978A-1A1617E173A6

Q34399831-E73707C1-AFA7-4E7F-8AFC-79AF3BFFC36E

Q34399831-F7F8D478-8985-4314-BA0F-29DE6CE6B899

Q34399831-FBBC7898-111C-4A92-ACB7-FF90A4BCB4D1

P577

Q34399831-AF89CE50-02A7-41F3-BAC2-6A608B88D9A6

P5875

Q34399831-E968DE35-AA6C-498C-9C02-49C011C91750

P698

Q34399831-DE52DC78-F276-4F1D-A6D0-C0FF6EE9A344

P921

Q34399831-025404EB-1DAA-4883-BCF6-8192B6B4089A

Q34399831-11B19C50-6D56-43E1-98D6-6518CFDBD232

Q34399831-58CFA31B-D830-44B3-A54E-6A9ECF2519B8

Q34399831-B8BB4264-0372-4B77-BA12-5ADAFBB7D895

P932

Q34399831-FA0364CC-79A9-4BD4-93C3-B6E237C15299

P356

P1433

The Journal of Infectious Diseases

P1476

Cytotoxic markers associate wi ...... modium falciparum sporozoites.

@en

P2093

Anne C Teirlinck

http://www.w3.org/2001/XMLSchema#string

Cornelus C Hermsen

http://www.w3.org/2001/XMLSchema#string

Else M Bijker

http://www.w3.org/2001/XMLSchema#string

Joanna IntHout

http://www.w3.org/2001/XMLSchema#string

Remko Schats

http://www.w3.org/2001/XMLSchema#string

P2860

Advances and challenges in malaria vaccine development

Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites

A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants

pROC: an open-source package for R and S+ to analyze and compare ROC curves

Imaging effector functions of human cytotoxic CD4+ T cells specific for Plasmodium falciparum circumsporozoite protein.

In vivo imaging of CD8+ T cell-mediated elimination of malaria liver stages.

CD8+ T cells specific for a malaria cytoplasmic antigen form clusters around infected hepatocytes and are protective at the liver stage of infection.

Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data.

A comparative investigation of methods for logistic regression with separated or nearly separated data.

Clinical outcome of experimental human malaria induced by Plasmodium falciparum-infected mosquitoes.

P304

1605-1615

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/INFDIS/JIU293

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

210

http://www.w3.org/2001/XMLSchema#string

P50

Lisette van Lieshout

Geert-Jan van Gemert

Marga van de Vegte-Bolmer

Robert W Sauerwein

P577

2014-05-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262693530

http://www.w3.org/2001/XMLSchema#string

P698

24872326

http://www.w3.org/2001/XMLSchema#string

P921

Plasmodium falciparum

P932

4208622

http://www.w3.org/2001/XMLSchema#string